FODOSINE Trademark

Trademark Overview

On Thursday, September 30, 2004, a trademark application was filed for FODOSINE with the United States Patent and Trademark Office. The USPTO has given the FODOSINE trademark a serial number of 78492452. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 11, 2016. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The FODOSINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas and immunological disorders such as transplant rejection
fodosine

General Information

Serial Number78492452
Word MarkFODOSINE
Filing DateThursday, September 30, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 11, 2016
Registration Number3665049
Registration DateTuesday, August 4, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2005

Trademark Statements

Goods and ServicesPharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas and immunological disorders such as transplant rejection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 11, 2016
Primary Code005
First Use Anywhere DateFriday, December 5, 2008
First Use In Commerce DateFriday, December 5, 2008

Trademark Owner History

Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBirmingham, AL, AL 352441879
Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham, AL, AL 352441879
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL, AL 352441879

Trademark Events

Event DateEvent Description
Friday, March 11, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, August 4, 2009REGISTERED-PRINCIPAL REGISTER
Friday, June 26, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 26, 2009ASSIGNED TO LIE
Monday, June 22, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 19, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 18, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 18, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 18, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 18, 2008NON-FINAL ACTION E-MAILED
Thursday, December 18, 2008SU - NON-FINAL ACTION - WRITTEN
Tuesday, December 16, 2008STATEMENT OF USE PROCESSING COMPLETE
Friday, December 5, 2008USE AMENDMENT FILED
Tuesday, December 16, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 5, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, June 3, 2008EXTENSION 5 GRANTED
Tuesday, June 3, 2008EXTENSION 5 FILED
Tuesday, June 3, 2008TEAS EXTENSION RECEIVED
Thursday, December 6, 2007EXTENSION 4 GRANTED
Thursday, December 6, 2007EXTENSION 4 FILED
Thursday, December 6, 2007TEAS EXTENSION RECEIVED
Thursday, August 9, 2007EXTENSION 3 GRANTED
Tuesday, May 8, 2007EXTENSION 3 FILED
Tuesday, May 8, 2007TEAS EXTENSION RECEIVED
Wednesday, January 17, 2007EXTENSION 2 GRANTED
Tuesday, November 21, 2006EXTENSION 2 FILED
Tuesday, November 21, 2006TEAS EXTENSION RECEIVED
Monday, June 5, 2006EXTENSION 1 GRANTED
Monday, June 5, 2006EXTENSION 1 FILED
Monday, June 5, 2006TEAS EXTENSION RECEIVED
Tuesday, December 6, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2005NOTICE OF PUBLICATION
Wednesday, May 18, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 11, 2005ASSIGNED TO LIE
Tuesday, May 3, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 2, 2005ASSIGNED TO EXAMINER
Friday, October 8, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

fodosine cell immunological disorders namely such cancers leukemias rejection transplant lymphomas